Treatment Outcomes of Early Carcinoma Cervix Before and After Sub-specialization

Springer Science and Business Media LLC - Tập 12 - Trang 78-85 - 2020
Vinotha Thomas1, Rachel G. Chandy1, Ajit Sebastian1, Anitha Thomas1, Dhanya S. Thomas1, Thomas S. Ram2, Abraham Peedicayil1
1Department of Gynaecologic Oncology, Christian Medical College, Vellore, India
2Department of Radiation Oncology, Christian Medical College, Vellore, India

Tóm tắt

This study aimed to compare the treatment outcomes in carcinoma cervix before and after gynecologic oncology sub-specialization at a tertiary care hospital, in India. This was a retrospective cohort study comparing women with operable cervical cancer who underwent radical hysterectomy before and after gynecologic oncology sub-specialization. Electronic medical records of women operated for early carcinoma cervix between 2001 and 2010 and 2011–2015 were reviewed and compared for treatment and oncological outcomes. Seventy-four patients were operated over 5 years after sub-specialization as against 59 over 10 years before sub-specialization, with similar clinical characteristics. After surgical-pathological examination, both cohorts were comparable with regard to mean tumor size, lymph nodes retrieved, deep stromal invasion, and involvement of lymph nodes, parametrium, and vaginal margins. After sub-specialization, the rate of intraoperative (3% versus 14%, p = 0.018) and postoperative complications (15% versus 46%, p < 0.001) was lower. Adjuvant radiation was used more after sub-specialization (50% versus 24%, p < 0.001). The follow-up rates were similar in both groups with comparable 5-year recurrence-free survival and overall survival rates. The hazard ratio for death after sub-specialization was 0.39 (95% CI 0.12 to 1.22) after adjusting for histology, stage, grade, and presence of intermediate or high risk factors. Gynecological oncologic sub-specialization decreased intraoperative and postoperative complications, improved pathological reporting, and enabled appropriate tailoring of adjuvant therapy.

Tài liệu tham khảo

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492 India State-Level Disease Burden Initiative Cancer Collaborators (2018) The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Oncol 19(10):1289–1306. https://doi.org/10.1016/S1470-2045(18)30447-9 Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M et al (2018). Global cancer observatory: cancer today [Internet]. Lyon, France: International Agency for Research on Cancer. c2019[accessed 2019 Dec 24]. Available from: https://gco.iarc.fr/today NICPR. Cancer Statistics [Internet]. c2020 [accessed 2020 Jan 10]. Available from : http://cancerindia.org.in/statistics Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human papillomavirus and related diseases in India. Summary Report 17 June 2019. [Internet]. c2020[accessed 2020 Jan 20]. Available from: https://hpvcentre.net/statistics/reports/IND.pdf Pramesh CS, Badwe RA, Borthakur BB, Chandra M, Raj EH, Kannan T, Kalwar A, Kapoor S, Malhotra H, Nayak S, Rath GK, Sagar TG, Sebastian P, Sarin R, Shanta V, Sharma SC, Shukla S, Vijayakumar M, Vijaykumar DK, Aggarwal A, Purushotham A, Sullivan R (2014) Delivery of affordable and equitable cancer care in India. Lancet Oncol 15:223–233. https://doi.org/10.1016/S1470-2045(14)70117-2 Sirohi B, Chalkidou K, Pramesh CS, Anderson BO, Loeher P, El Dewachi O et al (2018) Developing institutions for cancer care in low-income and middle-income countries: from cancer units to comprehensive cancer centres. Lancet Oncol 19:395–406. https://doi.org/10.1016/S1470-2045(18)30342-5 Gnanamalar A, Peedicayil A, Sebastian A, Thomas V, Thomas A, Chandy R (2019) The surgical and oncological outcomes of radical hysterectomy for early cervical cancer. Indian J Gynecol Oncol 17:16. https://doi.org/10.1007/s40944-019-0259-4 Jain A, Ganesh B, Bobdey SC, Sathwara JA, Saoba S (2017) Sociodemographic and clinical profile of cervical cancer patients visiting in a tertiary care hospital in India. Indian J Med Paediatr Oncol 38:291–295. https://doi.org/10.4103/ijmpo.ijmpo_20_16 Dahm-Kähler P, Palmqvist C, Staf C, Holmberg E, Johannesson L (2016) Centralized primary care of advanced ovarian cancer improves complete cytoreduction and survival - a population-based cohort study. Gynecol Oncol 142:211–216. https://doi.org/10.1016/j.ygyno.2016.05.025 Matsuo K, Shimada M, Yamaguchi S, Matoda M, Nakanishi T, Kikkawa F, Ohmichi M, Okamoto A, Sugiyama T, Mikami M (2019) Association of radical hysterectomy surgical volume and survival for early-stage cervical cancer. Obstet Gynecol 133:1086–1098. https://doi.org/10.1097/AOG.0000000000003280 Pecorelli S, Zigliani L, Odicino F (2009) Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 105:107–108. https://doi.org/10.1016/j.ijgo.2009.02.009 Hricak H, Gatsonis C, Chi DS, Amendola MA, Brandt K, Schwartz LH, Koelliker S, Siegelman ES, Brown JJ, McGhee RB Jr, Iyer R, Vitellas KM, Snyder B, Long HJ 3rd, Fiorica JV, Mitchell DG, American College of Radiology Imaging Network 6651, Gynecologic Oncology Group 183 (2005) Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 23:9329–9337. https://doi.org/10.1200/JCO.2005.02.0354 Bermudez A, Bhatla N, Leung E (2015) Cancer of the cervix uteri. Int J Gynaecol Obstet 131 Suppl2:S88–S95. https://doi.org/10.1016/j.ijgo.2015.06.004 Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R (2018) Cancer of the cervix uteri. Int J Gynaecol Obstet 143(Suppl 2):22–36. https://doi.org/10.1002/ijgo.12611 Amin MB (2010) The 2009 version of the cancer protocols of the college of American pathologists: a continuing journey from “guidelines for pathologists” to “standards for multidisciplinary comprehensive cancer care”. Arch Pathol Lab Med 134:326–330. https://doi.org/10.1043/1543-2165-134.3.326 Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI (2006) A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 65:169–176. https://doi.org/10.1016/j.ijrobp.2005.10.019 Cibula D, Planchamp F, Fischerova D, Fotopoulou C, Kohler C, Landoni F et al (2020) European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer. Int J Gynecol Cancer 30:3–14. https://doi.org/10.1016/j.ijrobp.2005.10.019 Leitao MM (2018) The LACC trial: has minimally invasive surgery for early-stage cervical cancer been dealt a knockout punch? Int J Gynecol Cancer 28:1248–1250. https://doi.org/10.1097/IGC.0000000000001342 Hanprasertpong J, Jiamset I (2017) Late recurrence of early stage cervical cancer more than 3 years after radical hysterectomy with pelvic node dissection. Oncol Res Treat 40:270–276. https://doi.org/10.1159/000464408 Metindir J, Bilir G (2007) Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy. Eur J Gynaecol Oncol 28:28–32 Wu MF, Li J, Lu HW, Wang LJ, Zhang BZ, Lin ZQ (2016) Impact of the care provided by gynecologic oncologists on outcomes of cervical cancer patients treated with radical hysterectomy. OncoTargets Ther 9:1361–1370. https://doi.org/10.2147/OTT.S99874 Ware RA, van Nagell JR (2010) Radical hysterectomy with pelvic lymphadenectomy: indications, technique, and complications. Obstet Gynecol Int 2010:1–9. https://doi.org/10.1155/2010/587610 Trimbos JB, Hellebrekers BWJ, Kenter GG, Peters LAW, Zwinderman KH (2000) The long learning curve of gynaecological cancer surgery: an argument for centralization. Br J Obstet Gynaecol 107:19–23. https://doi.org/10.1111/j.1471-0528.2000.tb11573.x Mikami M, Shida M, Shibata T, Katabuchi H, Kigawa J, Aoki D, Yaegashi N (2018) Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer. J Gynecol Oncol 29(2):e23. https://doi.org/10.3802/jgo.2018.29.e23